𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi’s sarcoma-associated herpesvirus

✍ Scribed by Fuqu Yu; Jiaying Feng; Josephine N. Harada; Sumit K. Chanda; Shannon C. Kenney; Ren Sun

Book ID
118442555
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
106 KB
Volume
581
Category
Article
ISSN
0014-5793

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal reactivation of Kaposi's sarcoma
Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines
✍ J. Paul Zoeteweij; Andrea S. Rinderknecht; David A. Davis; Robert Yarchoan; Andr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Corticosteroid use in transplant recipients increases the incidence and severity of Kaposi's sarcoma (KS), a disease associated with KS‐associated herpesvirus (KSHV) infection. Recently, the prototypic corticosteroid, hydrocortisone, was shown to directly induce lytic cycle reactivation

HIV-1 infection of primary effusion lymp
HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation
✍ Rastine Merat; Ali Amara; Celeste Lebbe; Hugues de The; Patrice Morel; Ali Saib 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 238 KB

## Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) is a gammaherpesvirus etiologically linked to primary effusion lymphoma (PEL), to a subset of multicentric Castleman's disease and to Kaposi's sarcoma (KS), the most common neoplasm associated with AIDS. Among KSHV‐infected individuals, the